Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas? View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-11

AUTHORS

Zhengfu Fan, Shreyaskumar Patel, Valerae O. Lewis, B. Ashleigh Guadagnolo, Patrick P. Lin

ABSTRACT

BACKGROUND: Extraosseous osteosarcoma is rare, and the most appropriate therapy is unclear because there are few studies regarding its treatment. The effectiveness of radiation and chemotherapy remains uncertain owing to conflicting results in previous reports. QUESTIONS/PURPOSES: To review our experience with contemporary multimodality treatment, we asked: (1) What is the disease-specific survival and local relapse-free survival? (2) Does American Joint Commission on Cancer (AJCC) stage, tumor size, or location relate to disease outcome? (3) Does radiation therapy improve local control or survival? (4) Do doxorubicin and ifosfamide improve local control or survival? METHODS: Between 1990 and 2012, we treated 40 patients for localized, high-grade extraosseous osteosarcoma. In this retrospective study, we could determine the status of 36 patients (90%) either to death or for a minimum of 24 months of followup; four (10%) were lost to followup before 24 months. There were 11 patients with AJCC Stage IIA and 25 with Stage III disease. All patients underwent wide surgical excision. Of the patients with Stage IIA disease, four received radiation and none received chemotherapy. Of the patients with Stage III disease, six received radiation, seven were treated with chemotherapy, and six received radiation and chemotherapy. During the study period, high-dose doxorubicin and ifosfamide was the preferred chemotherapy regimen for patients younger than 60 years with normal cardiac and renal function. Local relapse-free survival and disease-specific survival were determined by Kaplan-Meier analysis using a prospectively maintained institutional database supplemented by information from the institutional tumor registry. The Cox proportional hazard model was used to determine the effect of various factors on local recurrence and patient survival. RESULTS: At 5 years, local relapse-free survival was 47% (95% CI, 27%-64%), and disease-specific survival was 53% (95% CI, 35%-68%). In multivariate analysis, AJCC stage, which depends on tumor size, was the strongest predictor of local relapse-free survival (hazard ratio [HR] = 0.17, p = 0.02), while tumor depth was the best predictor of disease-specific survival (HR = 5.6, p = 0.02). Radiation improved local relapse-free survival (HR = 0.30, p = 0.03) but not disease-specific survival in multivariate analysis. A regimen of doxorubicin and ifosfamide was associated with better local relapse-free survival for patients with Stage III disease (HR = 0.16, p = 0.04) but not disease-specific survival (HR = 0.32, p = 0.08). CONCLUSIONS: With the limited number of patients in our study, it appears that extraosseous osteosarcoma behaves differently than osteosarcoma of bone. Multimodality treatment that includes doxorubicin and ifosfamide-based chemotherapy, radiation, and surgery may be a valid therapeutic strategy for Stage III disease, but larger, prospective studies will be needed to verify our preliminary observations. LEVEL OF EVIDENCE: Level III, therapeutic study. More... »

PAGES

3604-3611

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11999-015-4463-y

DOI

http://dx.doi.org/10.1007/s11999-015-4463-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049650178

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26197952


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoradiotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ifosfamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Grading", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteosarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteotomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Registries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Soft Tissue Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Burden", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Orthopaedic Oncology, Peking University Cancer Hospital & Institute, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fan", 
        "givenName": "Zhengfu", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Shreyaskumar", 
        "id": "sg:person.013307202747.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013307202747.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Orthopaedic Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1448, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lewis", 
        "givenName": "Valerae O.", 
        "id": "sg:person.0733301734.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733301734.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guadagnolo", 
        "givenName": "B. Ashleigh", 
        "id": "sg:person.01274344234.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274344234.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Orthopaedic Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1448, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lin", 
        "givenName": "Patrick P.", 
        "id": "sg:person.016135261767.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016135261767.27"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1080/13577140020008084", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000118359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19830215)51:4<727::aid-cncr2820510429>3.0.co;2-i", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001310220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001337137"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000073366", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002440437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19900615)65:12<2762::aid-cncr2820651226>3.0.co;2-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002996248"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11999-013-3022-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003535401", 
          "https://doi.org/10.1007/s11999-013-3022-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11999-013-3022-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003535401", 
          "https://doi.org/10.1007/s11999-013-3022-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1007/s11999-013-3022-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003535401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1007/s11999-013-3022-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003535401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdn678", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007416534"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2005.10.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008349460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19870901)60:5<1132::aid-cncr2820600536>3.0.co;2-l", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009127493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00776-007-1164-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010701846", 
          "https://doi.org/10.1007/s00776-007-1164-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-82982-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012455195", 
          "https://doi.org/10.1007/978-3-642-82982-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-82982-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012455195", 
          "https://doi.org/10.1007/978-3-642-82982-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-82982-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012455195", 
          "https://doi.org/10.1007/978-3-642-82982-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19951201)76:11<2253::aid-cncr2820761112>3.0.co;2-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015641956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/14737140.4.2.229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028222482"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1179/joc.2001.13.3.235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030210468"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-10-645", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036053542", 
          "https://doi.org/10.1186/1471-2407-10-645"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ssu.2980100105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046305764"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.02.057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049135493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1743-7563.2010.01278.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049226521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1743-7563.2010.01278.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049226521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00432-005-0687-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052072893", 
          "https://doi.org/10.1007/s00432-005-0687-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00432-005-0687-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052072893", 
          "https://doi.org/10.1007/s00432-005-0687-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00432-005-0687-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052072893", 
          "https://doi.org/10.1007/s00432-005-0687-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00432-005-0687-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052072893", 
          "https://doi.org/10.1007/s00432-005-0687-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/87.17.1331-a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059819469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.2.521", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.5.1238", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074777227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077134340", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1994.12.6.1137", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082698953"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-11", 
    "datePublishedReg": "2015-11-01", 
    "description": "BACKGROUND: Extraosseous osteosarcoma is rare, and the most appropriate therapy is unclear because there are few studies regarding its treatment. The effectiveness of radiation and chemotherapy remains uncertain owing to conflicting results in previous reports.\nQUESTIONS/PURPOSES: To review our experience with contemporary multimodality treatment, we asked: (1) What is the disease-specific survival and local relapse-free survival? (2) Does American Joint Commission on Cancer (AJCC) stage, tumor size, or location relate to disease outcome? (3) Does radiation therapy improve local control or survival? (4) Do doxorubicin and ifosfamide improve local control or survival?\nMETHODS: Between 1990 and 2012, we treated 40 patients for localized, high-grade extraosseous osteosarcoma. In this retrospective study, we could determine the status of 36 patients (90%) either to death or for a minimum of 24 months of followup; four (10%) were lost to followup before 24 months. There were 11 patients with AJCC Stage IIA and 25 with Stage III disease. All patients underwent wide surgical excision. Of the patients with Stage IIA disease, four received radiation and none received chemotherapy. Of the patients with Stage III disease, six received radiation, seven were treated with chemotherapy, and six received radiation and chemotherapy. During the study period, high-dose doxorubicin and ifosfamide was the preferred chemotherapy regimen for patients younger than 60 years with normal cardiac and renal function. Local relapse-free survival and disease-specific survival were determined by Kaplan-Meier analysis using a prospectively maintained institutional database supplemented by information from the institutional tumor registry. The Cox proportional hazard model was used to determine the effect of various factors on local recurrence and patient survival.\nRESULTS: At 5 years, local relapse-free survival was 47% (95% CI, 27%-64%), and disease-specific survival was 53% (95% CI, 35%-68%). In multivariate analysis, AJCC stage, which depends on tumor size, was the strongest predictor of local relapse-free survival (hazard ratio [HR] = 0.17, p = 0.02), while tumor depth was the best predictor of disease-specific survival (HR = 5.6, p = 0.02). Radiation improved local relapse-free survival (HR = 0.30, p = 0.03) but not disease-specific survival in multivariate analysis. A regimen of doxorubicin and ifosfamide was associated with better local relapse-free survival for patients with Stage III disease (HR = 0.16, p = 0.04) but not disease-specific survival (HR = 0.32, p = 0.08).\nCONCLUSIONS: With the limited number of patients in our study, it appears that extraosseous osteosarcoma behaves differently than osteosarcoma of bone. Multimodality treatment that includes doxorubicin and ifosfamide-based chemotherapy, radiation, and surgery may be a valid therapeutic strategy for Stage III disease, but larger, prospective studies will be needed to verify our preliminary observations.\nLEVEL OF EVIDENCE: Level III, therapeutic study.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11999-015-4463-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1007212", 
        "issn": [
          "0009-921X", 
          "1528-1132"
        ], 
        "name": "Clinical Orthopaedics and Related Research\u00ae", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "473"
      }
    ], 
    "name": "Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?", 
    "pagination": "3604-3611", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ec84c50dd61d8902bf8f79a20f1cdb5e93b6a0a0fb148f9576592947b611bf3f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26197952"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0075674"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11999-015-4463-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049650178"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11999-015-4463-y", 
      "https://app.dimensions.ai/details/publication/pub.1049650178"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000524.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11999-015-4463-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11999-015-4463-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11999-015-4463-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11999-015-4463-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11999-015-4463-y'


 

This table displays all metadata directly associated to this object as RDF triples.

275 TRIPLES      21 PREDICATES      78 URIs      45 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11999-015-4463-y schema:about N040c4a8359574ee99a63964b955d6942
2 N04491612700349b98a36c0fa01f8b16c
3 N0f49dfe3930e48b1b71f7c8a5e9ee6f8
4 N1b58815aa1084c2b87942e879421f503
5 N20e513e497bc49e08bfe5334ee5a1727
6 N231294e5bae3444e9f8933a260a7b682
7 N397021e030714e2cb8e34e5b39d832b6
8 N3eabb162899a49b18d77cf3948cbb15f
9 N462a897c3ae6454684d95e29854b9e82
10 N68fda0d3656f4da5913b9bb1d4080e00
11 N696f3659c48b4e81906574226fe300ee
12 N7d629850e37c477c9a79a2676aa7e9af
13 N8fca2153ff684e0d87e9519e1e200675
14 Na26794c54368464dac76a34de52af94c
15 Na38b73d026fd45e09b5bbd8d349d3848
16 Nb69679fa4a20492bbc6d49ba8b1aab63
17 Nb74d4c3a645842aca76f7cd82541bbcf
18 Nb7968b091f7f4fd5ab962afdd3695c42
19 Nbfcaf2ae53a94617aab951ac4ca6bbbb
20 Nce4d555764b6416284d3130acb2d50ae
21 Nd78942054b714ba89e7be573f4e19532
22 Ne51945c4d1824b469c152b3b3da4e84d
23 Nf9df6d0b343b4feaad9a748caad339e8
24 Nfa1df581368e4175b4aaf817ff1dc478
25 anzsrc-for:11
26 anzsrc-for:1112
27 schema:author Ncb9486d9384d46688046173f217a70cb
28 schema:citation sg:pub.10.1007/978-3-642-82982-6
29 sg:pub.10.1007/s00432-005-0687-7
30 sg:pub.10.1007/s00776-007-1164-8
31 sg:pub.10.1007/s11999-013-3022-7
32 sg:pub.10.1186/1471-2407-10-645
33 https://app.dimensions.ai/details/publication/pub.1077134340
34 https://doi.org/10.1002/1097-0142(19830215)51:4<727::aid-cncr2820510429>3.0.co;2-i
35 https://doi.org/10.1002/1097-0142(19870901)60:5<1132::aid-cncr2820600536>3.0.co;2-l
36 https://doi.org/10.1002/1097-0142(19900615)65:12<2762::aid-cncr2820651226>3.0.co;2-k
37 https://doi.org/10.1002/1097-0142(19951201)76:11<2253::aid-cncr2820761112>3.0.co;2-8
38 https://doi.org/10.1002/cncr.23592
39 https://doi.org/10.1002/ssu.2980100105
40 https://doi.org/10.1007/s11999-013-3022-7
41 https://doi.org/10.1016/j.ctrv.2005.10.003
42 https://doi.org/10.1080/13577140020008084
43 https://doi.org/10.1093/annonc/mdn678
44 https://doi.org/10.1093/jnci/87.17.1331-a
45 https://doi.org/10.1111/j.1743-7563.2010.01278.x
46 https://doi.org/10.1159/000073366
47 https://doi.org/10.1179/joc.2001.13.3.235
48 https://doi.org/10.1200/jco.1994.12.6.1137
49 https://doi.org/10.1200/jco.20.2.521
50 https://doi.org/10.1200/jco.2001.19.5.1238
51 https://doi.org/10.1200/jco.2004.02.057
52 https://doi.org/10.1586/14737140.4.2.229
53 schema:datePublished 2015-11
54 schema:datePublishedReg 2015-11-01
55 schema:description BACKGROUND: Extraosseous osteosarcoma is rare, and the most appropriate therapy is unclear because there are few studies regarding its treatment. The effectiveness of radiation and chemotherapy remains uncertain owing to conflicting results in previous reports. QUESTIONS/PURPOSES: To review our experience with contemporary multimodality treatment, we asked: (1) What is the disease-specific survival and local relapse-free survival? (2) Does American Joint Commission on Cancer (AJCC) stage, tumor size, or location relate to disease outcome? (3) Does radiation therapy improve local control or survival? (4) Do doxorubicin and ifosfamide improve local control or survival? METHODS: Between 1990 and 2012, we treated 40 patients for localized, high-grade extraosseous osteosarcoma. In this retrospective study, we could determine the status of 36 patients (90%) either to death or for a minimum of 24 months of followup; four (10%) were lost to followup before 24 months. There were 11 patients with AJCC Stage IIA and 25 with Stage III disease. All patients underwent wide surgical excision. Of the patients with Stage IIA disease, four received radiation and none received chemotherapy. Of the patients with Stage III disease, six received radiation, seven were treated with chemotherapy, and six received radiation and chemotherapy. During the study period, high-dose doxorubicin and ifosfamide was the preferred chemotherapy regimen for patients younger than 60 years with normal cardiac and renal function. Local relapse-free survival and disease-specific survival were determined by Kaplan-Meier analysis using a prospectively maintained institutional database supplemented by information from the institutional tumor registry. The Cox proportional hazard model was used to determine the effect of various factors on local recurrence and patient survival. RESULTS: At 5 years, local relapse-free survival was 47% (95% CI, 27%-64%), and disease-specific survival was 53% (95% CI, 35%-68%). In multivariate analysis, AJCC stage, which depends on tumor size, was the strongest predictor of local relapse-free survival (hazard ratio [HR] = 0.17, p = 0.02), while tumor depth was the best predictor of disease-specific survival (HR = 5.6, p = 0.02). Radiation improved local relapse-free survival (HR = 0.30, p = 0.03) but not disease-specific survival in multivariate analysis. A regimen of doxorubicin and ifosfamide was associated with better local relapse-free survival for patients with Stage III disease (HR = 0.16, p = 0.04) but not disease-specific survival (HR = 0.32, p = 0.08). CONCLUSIONS: With the limited number of patients in our study, it appears that extraosseous osteosarcoma behaves differently than osteosarcoma of bone. Multimodality treatment that includes doxorubicin and ifosfamide-based chemotherapy, radiation, and surgery may be a valid therapeutic strategy for Stage III disease, but larger, prospective studies will be needed to verify our preliminary observations. LEVEL OF EVIDENCE: Level III, therapeutic study.
56 schema:genre research_article
57 schema:inLanguage en
58 schema:isAccessibleForFree true
59 schema:isPartOf N14e0f565e3df4b7cb1b4b8a706f6cb39
60 Nd384ccdde5964a88b4fce20dd89e98a6
61 sg:journal.1007212
62 schema:name Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
63 schema:pagination 3604-3611
64 schema:productId N6b11747b4c7a467d9f9971e44fd9c00d
65 N8db05033fe8448bda355e7d17112a22f
66 N9e8df05b2eb44ac4a3107c7978e0292d
67 Na6d9a3dc42e34a7ab5e9e60311f27af9
68 Na73b6aab7c49449db1639c8e562023ab
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049650178
70 https://doi.org/10.1007/s11999-015-4463-y
71 schema:sdDatePublished 2019-04-10T22:35
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N4cca3da9e720446a9e294c9176f14911
74 schema:url http://link.springer.com/10.1007%2Fs11999-015-4463-y
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N02b337d857ed49d8ab1a038d81603273 rdf:first sg:person.0733301734.15
79 rdf:rest Nb9d847d1f1104605863472fb378b4ff9
80 N02c645ed60984744b98ffdc0484a02a4 schema:name Department of Orthopaedic Oncology, Peking University Cancer Hospital & Institute, Beijing, China
81 rdf:type schema:Organization
82 N040c4a8359574ee99a63964b955d6942 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Osteosarcoma
84 rdf:type schema:DefinedTerm
85 N04491612700349b98a36c0fa01f8b16c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Proportional Hazards Models
87 rdf:type schema:DefinedTerm
88 N0f49dfe3930e48b1b71f7c8a5e9ee6f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Kaplan-Meier Estimate
90 rdf:type schema:DefinedTerm
91 N14e0f565e3df4b7cb1b4b8a706f6cb39 schema:volumeNumber 473
92 rdf:type schema:PublicationVolume
93 N1b58815aa1084c2b87942e879421f503 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Doxorubicin
95 rdf:type schema:DefinedTerm
96 N20e513e497bc49e08bfe5334ee5a1727 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Neoplasm Recurrence, Local
98 rdf:type schema:DefinedTerm
99 N215c3b1ea4474a1dacf0deff3fe5b0ae schema:affiliation N02c645ed60984744b98ffdc0484a02a4
100 schema:familyName Fan
101 schema:givenName Zhengfu
102 rdf:type schema:Person
103 N231294e5bae3444e9f8933a260a7b682 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Disease Progression
105 rdf:type schema:DefinedTerm
106 N315fadb522be4f1a8cf2b891a9df7405 rdf:first sg:person.013307202747.74
107 rdf:rest N02b337d857ed49d8ab1a038d81603273
108 N397021e030714e2cb8e34e5b39d832b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Tumor Burden
110 rdf:type schema:DefinedTerm
111 N3eabb162899a49b18d77cf3948cbb15f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Ifosfamide
113 rdf:type schema:DefinedTerm
114 N462a897c3ae6454684d95e29854b9e82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Neoplasm Grading
116 rdf:type schema:DefinedTerm
117 N4cca3da9e720446a9e294c9176f14911 schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 N68fda0d3656f4da5913b9bb1d4080e00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Osteotomy
121 rdf:type schema:DefinedTerm
122 N696f3659c48b4e81906574226fe300ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Chemoradiotherapy, Adjuvant
124 rdf:type schema:DefinedTerm
125 N6b11747b4c7a467d9f9971e44fd9c00d schema:name nlm_unique_id
126 schema:value 0075674
127 rdf:type schema:PropertyValue
128 N7d629850e37c477c9a79a2676aa7e9af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Risk Factors
130 rdf:type schema:DefinedTerm
131 N8db05033fe8448bda355e7d17112a22f schema:name pubmed_id
132 schema:value 26197952
133 rdf:type schema:PropertyValue
134 N8fca2153ff684e0d87e9519e1e200675 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Time Factors
136 rdf:type schema:DefinedTerm
137 N9e8df05b2eb44ac4a3107c7978e0292d schema:name dimensions_id
138 schema:value pub.1049650178
139 rdf:type schema:PropertyValue
140 Na26794c54368464dac76a34de52af94c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Neoplasm Staging
142 rdf:type schema:DefinedTerm
143 Na38b73d026fd45e09b5bbd8d349d3848 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Retrospective Studies
145 rdf:type schema:DefinedTerm
146 Na6d9a3dc42e34a7ab5e9e60311f27af9 schema:name readcube_id
147 schema:value ec84c50dd61d8902bf8f79a20f1cdb5e93b6a0a0fb148f9576592947b611bf3f
148 rdf:type schema:PropertyValue
149 Na73b6aab7c49449db1639c8e562023ab schema:name doi
150 schema:value 10.1007/s11999-015-4463-y
151 rdf:type schema:PropertyValue
152 Nb69679fa4a20492bbc6d49ba8b1aab63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Radiotherapy, Adjuvant
154 rdf:type schema:DefinedTerm
155 Nb74d4c3a645842aca76f7cd82541bbcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Disease-Free Survival
157 rdf:type schema:DefinedTerm
158 Nb7968b091f7f4fd5ab962afdd3695c42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Soft Tissue Neoplasms
160 rdf:type schema:DefinedTerm
161 Nb9d847d1f1104605863472fb378b4ff9 rdf:first sg:person.01274344234.32
162 rdf:rest Nf67024958f1440dda116d9c3ea4723e1
163 Nbfcaf2ae53a94617aab951ac4ca6bbbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Chemotherapy, Adjuvant
165 rdf:type schema:DefinedTerm
166 Ncb9486d9384d46688046173f217a70cb rdf:first N215c3b1ea4474a1dacf0deff3fe5b0ae
167 rdf:rest N315fadb522be4f1a8cf2b891a9df7405
168 Nce4d555764b6416284d3130acb2d50ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Multivariate Analysis
170 rdf:type schema:DefinedTerm
171 Nd384ccdde5964a88b4fce20dd89e98a6 schema:issueNumber 11
172 rdf:type schema:PublicationIssue
173 Nd78942054b714ba89e7be573f4e19532 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Registries
175 rdf:type schema:DefinedTerm
176 Ne51945c4d1824b469c152b3b3da4e84d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Humans
178 rdf:type schema:DefinedTerm
179 Nf67024958f1440dda116d9c3ea4723e1 rdf:first sg:person.016135261767.27
180 rdf:rest rdf:nil
181 Nf9df6d0b343b4feaad9a748caad339e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Treatment Outcome
183 rdf:type schema:DefinedTerm
184 Nfa1df581368e4175b4aaf817ff1dc478 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Antineoplastic Combined Chemotherapy Protocols
186 rdf:type schema:DefinedTerm
187 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
188 schema:name Medical and Health Sciences
189 rdf:type schema:DefinedTerm
190 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
191 schema:name Oncology and Carcinogenesis
192 rdf:type schema:DefinedTerm
193 sg:journal.1007212 schema:issn 0009-921X
194 1528-1132
195 schema:name Clinical Orthopaedics and Related Research®
196 rdf:type schema:Periodical
197 sg:person.01274344234.32 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
198 schema:familyName Guadagnolo
199 schema:givenName B. Ashleigh
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274344234.32
201 rdf:type schema:Person
202 sg:person.013307202747.74 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
203 schema:familyName Patel
204 schema:givenName Shreyaskumar
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013307202747.74
206 rdf:type schema:Person
207 sg:person.016135261767.27 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
208 schema:familyName Lin
209 schema:givenName Patrick P.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016135261767.27
211 rdf:type schema:Person
212 sg:person.0733301734.15 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
213 schema:familyName Lewis
214 schema:givenName Valerae O.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733301734.15
216 rdf:type schema:Person
217 sg:pub.10.1007/978-3-642-82982-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012455195
218 https://doi.org/10.1007/978-3-642-82982-6
219 rdf:type schema:CreativeWork
220 sg:pub.10.1007/s00432-005-0687-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052072893
221 https://doi.org/10.1007/s00432-005-0687-7
222 rdf:type schema:CreativeWork
223 sg:pub.10.1007/s00776-007-1164-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010701846
224 https://doi.org/10.1007/s00776-007-1164-8
225 rdf:type schema:CreativeWork
226 sg:pub.10.1007/s11999-013-3022-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003535401
227 https://doi.org/10.1007/s11999-013-3022-7
228 rdf:type schema:CreativeWork
229 sg:pub.10.1186/1471-2407-10-645 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036053542
230 https://doi.org/10.1186/1471-2407-10-645
231 rdf:type schema:CreativeWork
232 https://app.dimensions.ai/details/publication/pub.1077134340 schema:CreativeWork
233 https://doi.org/10.1002/1097-0142(19830215)51:4<727::aid-cncr2820510429>3.0.co;2-i schema:sameAs https://app.dimensions.ai/details/publication/pub.1001310220
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1002/1097-0142(19870901)60:5<1132::aid-cncr2820600536>3.0.co;2-l schema:sameAs https://app.dimensions.ai/details/publication/pub.1009127493
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1002/1097-0142(19900615)65:12<2762::aid-cncr2820651226>3.0.co;2-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1002996248
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1002/1097-0142(19951201)76:11<2253::aid-cncr2820761112>3.0.co;2-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015641956
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1002/cncr.23592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001337137
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1002/ssu.2980100105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046305764
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1007/s11999-013-3022-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003535401
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1016/j.ctrv.2005.10.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008349460
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1080/13577140020008084 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000118359
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1093/annonc/mdn678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007416534
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1093/jnci/87.17.1331-a schema:sameAs https://app.dimensions.ai/details/publication/pub.1059819469
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1111/j.1743-7563.2010.01278.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049226521
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1159/000073366 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002440437
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1179/joc.2001.13.3.235 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030210468
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1200/jco.1994.12.6.1137 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082698953
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1200/jco.20.2.521 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202769
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1200/jco.2001.19.5.1238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074777227
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1200/jco.2004.02.057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049135493
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1586/14737140.4.2.229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028222482
270 rdf:type schema:CreativeWork
271 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
272 schema:name Department of Orthopaedic Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1448, 77030, Houston, TX, USA
273 Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
274 Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
275 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...